Sort
261,768 grants matching “gene therapy”
Chemical Biology Platforms to Define the Metabolism-Epigenetics Interface
$2,478,596Jordan Leslie Meier · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Targeted Therapies in Melanoma
$2,478,587Meenhard Herlyn · Wistar Institute · P01 · FY2023 · CA
Combination Therapies to Defeat Melanoma Resistance
$2,478,520Antoni Ribas · University Of California Los Angeles · P01 · FY2024 · CA
Translational Studies in FLASH Particle Radiotherapy
$2,478,484Constantinos Koumenis · University Of Pennsylvania · P01 · FY2022 · CA
Pharmaceutical Research Center
$2,477,561Henry Lewis · Florida Agricultural And Mechanical Univ · G12 · FY2008 · RR
Depression, Biobehavioral Mechanisms, & CHD/Mortality Outcomes
$2,477,300Karina W. Davidson · Columbia University Health Sciences · P01 · FY2009 · HL
SPORE in Prostate Cancer
$2,476,722Mayo Clinic · P50 · FY2004 · CA
Functional consequences of stem and progenitor cell heterogeneity
$2,475,971David T Scadden · Massachusetts General Hospital · P01 · FY2024 · HL
HPMI: Host Pathogen Mapping Initiative
$2,475,950Nevan J Krogan · University Of California, San Francisco · U19 · FY2024 · AI
Comprehensive Structural and Functional Mapping of Mammalian Colonic Nervous System
$2,475,057Yvette France Tache · University Of California Los Angeles · OT2 · FY2018 · OD
Routes to enhanced HIV neuropathogenesis through expression of subclinical levels of endogenous amyloid-beta
$2,475,013David J Volsky · Icahn School Of Medicine At Mount Sinai · RF1 · FY2022 · NS
Extending the Phenotype of Nonsyndromic Orofacial Clefting
$2,474,971Mary L Marazita · University Of Pittsburgh At Pittsburgh · R01 · FY2016 · DE
The Role of TIMPs in Cell Growth and Differentiation: Tumor Angiogenesis
$2,474,858William G Stetler-Stevenson · Division Of Clinical Sciences - Nci · Z01 · FY2008 · CA
Human autism genetics and activity dependent gene activation
$2,474,114Christopher A Walsh · Boston Children'S Hospital · RC2 · FY2009 · MH
Elucidating factors that modulate tauopathy and cellular degeneration to guide therapeutic development
$2,473,595Jada M Lewis · University Of Florida · RF1 · FY2019 · AG
Foamy Viral Gene Therapy for X-linked Severe Combined Immune Deficiency
$2,472,869David J Rawlings · Seattle Children'S Hospital · P01 · FY2014 · AI
Fred Hutchinson Cancer Center Lung SPORE
$2,471,718A. McGarry Houghton · Fred Hutchinson Cancer Center · P50 · FY2025 · CA
Regulation Of Childhood Growth
$2,471,547Jeffrey Baron · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2025 · HD
Mechanisms and treatment of retinal degeneration in animal models and humans
$2,471,232Paul Sieving · National Institute On Deafness And Other Communication Disorders · Z01 · FY2008 · DC
Genetic and Biochemical Approaches to Tyrosine Kinase and Lymphocyte Signaling
$2,471,222Pamela Schwartzberg · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Gene Therapy for Leber Congenital Amaurosis
$2,471,068University Of Florida · U10 · FY2003 · EY
Attacking failure of antibiotic treatment by targeting antimicrobial resistance enabler cell-states
$2,470,464Tim Van Opijnen · Boston Children'S Hospital · U19 · FY2025 · AI
Lentiviral Gene Therapy for Sickle Cell Disease and Immunodeficiency Disorders
$2,469,009Brian P Sorrentino · St. Jude Children'S Research Hospital · P01 · FY2010 · HL
Foamy Viral Gene Therapy for X-linked Severe Combined Immune Deficiency
$2,468,981David J Rawlings · Seattle Children'S Hospital · P01 · FY2015 · AI
SPORE in Lung Cancer
$2,468,469Vanderbilt University · P50 · FY2005 · CA